Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 128 Pages
Report ld: 6468683
Request Sample
Customized Report
Blood Clotting Analysers Market Size(US$)

CAGR 2026-2032
5.9%
Market Size,2032
USD 5,006
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Blood Clotting Analysers market was valued at US$ 3370 million in 2025 and is anticipated to reach US$ 5006 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Blood Clotting Analysers competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Blood clotting analysers are widely used point-of-care (POC) testing devices found primarily in cardiothoracic surgical suites and cardia catheterization laboratories. Most of these devices can perform a number of coagulation tests that provide information about a patient"s blood clotting status.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. The market for coagulation analyzers is expected to witness significant growth due to surging demand for coagulation analyzers across the world owing to growing awareness in healthcare systems. The introduction of new coagulation analyzer tests and rapid technological advancements have improved the efficiency and quality of hemostasis laboratories. That"s because these advanced coagulators offer high throughput, reliability, and adaptability, along with precision, accuracy, and easy-to-use software with built-in graphics and calibration curves. Growing awareness of the risks of cardiovascular disease, obesity and high blood pressure has forced people to gather in hospitals and healthcare facilities for routine blood tests. This is expected to aid in the expansion of the coagulation analyzer market and motivate manufacturers to develop better and faster testing methods. Nonetheless, risk of side effects associated with blood testing, coupled with stringent regulations imposed by the government on the approval of coagulation testing devices, are estimated to hamper the demand for hemostasis analyzers. Conversely, sales of coagulation analyzers are likely to increase as manufacturers increasingly rely on expanding their product portfolios to e-commerce platforms.
This report delivers a comprehensive overview of the global Blood Clotting Analysers market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood Clotting Analysers. The Blood Clotting Analysers market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blood Clotting Analysers market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blood Clotting Analysers manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Blood Clotting Analysers manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Blood Clotting Analysers sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Blood Clotting Analysers Market Overview
1.1 Product Definition
1.2 Blood Clotting Analysers by Type
1.2.1 Global Blood Clotting Analysers Market Value by Type: 2025 vs 2032
1.2.2 Standalone Analysers
1.2.3 Table Top Analysers
1.2.4 Portable Analysers
1.3 Blood Clotting Analysers by Application
1.3.1 Global Blood Clotting Analysers Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Others
1.4 Global Blood Clotting Analysers Market Size Estimates and Forecasts
1.4.1 Global Blood Clotting Analysers Revenue 2021–2032
1.4.2 Global Blood Clotting Analysers Sales 2021–2032
1.4.3 Global Blood Clotting Analysers Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Blood Clotting Analysers Market Competition by Manufacturers
2.1 Global Blood Clotting Analysers Sales Market Share by Manufacturers (2021–2026)
2.2 Global Blood Clotting Analysers Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Blood Clotting Analysers Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Blood Clotting Analysers, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Blood Clotting Analysers, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Blood Clotting Analysers, Product Types and Applications
2.7 Global Key Manufacturers of Blood Clotting Analysers, Date of Entry into the Industry
2.8 Global Blood Clotting Analysers Market Competitive Situation and Trends
2.8.1 Global Blood Clotting Analysers Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Blood Clotting Analysers Players Market Share by Revenue
2.8.3 Global Blood Clotting Analysers Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood Clotting Analysers Market Scenario by Region
3.1 Global Blood Clotting Analysers Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Blood Clotting Analysers Sales by Region: 2021–2032
3.2.1 Global Blood Clotting Analysers Sales by Region: 2021–2026
3.2.2 Global Blood Clotting Analysers Sales by Region: 2027–2032
3.3 Global Blood Clotting Analysers Revenue by Region: 2021–2032
3.3.1 Global Blood Clotting Analysers Revenue by Region: 2021–2026
3.3.2 Global Blood Clotting Analysers Revenue by Region: 2027–2032
3.4 North America Blood Clotting Analysers Market Facts & Figures by Country
3.4.1 North America Blood Clotting Analysers Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Blood Clotting Analysers Sales by Country (2021–2032)
3.4.3 North America Blood Clotting Analysers Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blood Clotting Analysers Market Facts & Figures by Country
3.5.1 Europe Blood Clotting Analysers Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Blood Clotting Analysers Sales by Country (2021–2032)
3.5.3 Europe Blood Clotting Analysers Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Clotting Analysers Market Facts & Figures by Region
3.6.1 Asia Pacific Blood Clotting Analysers Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Blood Clotting Analysers Sales by Region (2021–2032)
3.6.3 Asia Pacific Blood Clotting Analysers Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Blood Clotting Analysers Market Facts & Figures by Country
3.7.1 Latin America Blood Clotting Analysers Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Blood Clotting Analysers Sales by Country (2021–2032)
3.7.3 Latin America Blood Clotting Analysers Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Clotting Analysers Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Clotting Analysers Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Blood Clotting Analysers Sales by Country (2021–2032)
3.8.3 Middle East and Africa Blood Clotting Analysers Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blood Clotting Analysers Sales by Type (2021–2032)
4.1.1 Global Blood Clotting Analysers Sales by Type (2021–2026)
4.1.2 Global Blood Clotting Analysers Sales by Type (2027–2032)
4.1.3 Global Blood Clotting Analysers Sales Market Share by Type (2021–2032)
4.2 Global Blood Clotting Analysers Revenue by Type (2021–2032)
4.2.1 Global Blood Clotting Analysers Revenue by Type (2021–2026)
4.2.2 Global Blood Clotting Analysers Revenue by Type (2027–2032)
4.2.3 Global Blood Clotting Analysers Revenue Market Share by Type (2021–2032)
4.3 Global Blood Clotting Analysers Price by Type (2021–2032)
5 Segment by Application
5.1 Global Blood Clotting Analysers Sales by Application (2021–2032)
5.1.1 Global Blood Clotting Analysers Sales by Application (2021–2026)
5.1.2 Global Blood Clotting Analysers Sales by Application (2027–2032)
5.1.3 Global Blood Clotting Analysers Sales Market Share by Application (2021–2032)
5.2 Global Blood Clotting Analysers Revenue by Application (2021–2032)
5.2.1 Global Blood Clotting Analysers Revenue by Application (2021–2026)
5.2.2 Global Blood Clotting Analysers Revenue by Application (2027–2032)
5.2.3 Global Blood Clotting Analysers Revenue Market Share by Application (2021–2032)
5.3 Global Blood Clotting Analysers Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Siemens
6.1.1 Siemens Company Information
6.1.2 Siemens Description and Business Overview
6.1.3 Siemens Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Siemens Blood Clotting Analysers Product Portfolio
6.1.5 Siemens Recent Developments/Updates
6.2 Instrumentation Laboratory
6.2.1 Instrumentation Laboratory Company Information
6.2.2 Instrumentation Laboratory Description and Business Overview
6.2.3 Instrumentation Laboratory Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Instrumentation Laboratory Blood Clotting Analysers Product Portfolio
6.2.5 Instrumentation Laboratory Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Roche Blood Clotting Analysers Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Mindray
6.4.1 Mindray Company Information
6.4.2 Mindray Description and Business Overview
6.4.3 Mindray Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Mindray Blood Clotting Analysers Product Portfolio
6.4.5 Mindray Recent Developments/Updates
6.5 MRC
6.5.1 MRC Company Information
6.5.2 MRC Description and Business Overview
6.5.3 MRC Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 MRC Blood Clotting Analysers Product Portfolio
6.5.5 MRC Recent Developments/Updates
6.6 Helena Laboratories
6.6.1 Helena Laboratories Company Information
6.6.2 Helena Laboratories Description and Business Overview
6.6.3 Helena Laboratories Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Helena Laboratories Blood Clotting Analysers Product Portfolio
6.6.5 Helena Laboratories Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.7.1 Thermo Fisher Scientific Company Information
6.7.2 Thermo Fisher Scientific Description and Business Overview
6.7.3 Thermo Fisher Scientific Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Thermo Fisher Scientific Blood Clotting Analysers Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 ERBA Diagnostics Mannheim
6.8.1 ERBA Diagnostics Mannheim Company Information
6.8.2 ERBA Diagnostics Mannheim Description and Business Overview
6.8.3 ERBA Diagnostics Mannheim Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 ERBA Diagnostics Mannheim Blood Clotting Analysers Product Portfolio
6.8.5 ERBA Diagnostics Mannheim Recent Developments/Updates
6.9 Rayto Life and Analytical Sciences
6.9.1 Rayto Life and Analytical Sciences Company Information
6.9.2 Rayto Life and Analytical Sciences Description and Business Overview
6.9.3 Rayto Life and Analytical Sciences Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Rayto Life and Analytical Sciences Blood Clotting Analysers Product Portfolio
6.9.5 Rayto Life and Analytical Sciences Recent Developments/Updates
6.10 Nihon Kohden Corporation
6.10.1 Nihon Kohden Corporation Company Information
6.10.2 Nihon Kohden Corporation Description and Business Overview
6.10.3 Nihon Kohden Corporation Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Nihon Kohden Corporation Blood Clotting Analysers Product Portfolio
6.10.5 Nihon Kohden Corporation Recent Developments/Updates
6.11 Beckman Coulter Inc. (Danaher Corporation)
6.11.1 Beckman Coulter Inc. (Danaher Corporation) Company Information
6.11.2 Beckman Coulter Inc. (Danaher Corporation) Description and Business Overview
6.11.3 Beckman Coulter Inc. (Danaher Corporation) Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Beckman Coulter Inc. (Danaher Corporation) Blood Clotting Analysers Product Portfolio
6.11.5 Beckman Coulter Inc. (Danaher Corporation) Recent Developments/Updates
6.12 Sysmex Corporation
6.12.1 Sysmex Corporation Company Information
6.12.2 Sysmex Corporation Description and Business Overview
6.12.3 Sysmex Corporation Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sysmex Corporation Blood Clotting Analysers Product Portfolio
6.12.5 Sysmex Corporation Recent Developments/Updates
6.13 Abbott Laboratories
6.13.1 Abbott Laboratories Company Information
6.13.2 Abbott Laboratories Description and Business Overview
6.13.3 Abbott Laboratories Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Abbott Laboratories Blood Clotting Analysers Product Portfolio
6.13.5 Abbott Laboratories Recent Developments/Updates
6.14 HORIBA Medical
6.14.1 HORIBA Medical Company Information
6.14.2 HORIBA Medical Description and Business Overview
6.14.3 HORIBA Medical Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 HORIBA Medical Blood Clotting Analysers Product Portfolio
6.14.5 HORIBA Medical Recent Developments/Updates
6.15 DIRUI Industrial
6.15.1 DIRUI Industrial Company Information
6.15.2 DIRUI Industrial Description and Business Overview
6.15.3 DIRUI Industrial Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 DIRUI Industrial Blood Clotting Analysers Product Portfolio
6.15.5 DIRUI Industrial Recent Developments/Updates
6.16 Seleo
6.16.1 Seleo Company Information
6.16.2 Seleo Description and Business Overview
6.16.3 Seleo Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Seleo Blood Clotting Analysers Product Portfolio
6.16.5 Seleo Recent Developments/Updates
6.17 Zircon Biotech
6.17.1 Zircon Biotech Company Information
6.17.2 Zircon Biotech Description and Business Overview
6.17.3 Zircon Biotech Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Zircon Biotech Blood Clotting Analysers Product Portfolio
6.17.5 Zircon Biotech Recent Developments/Updates
6.18 Beijing Succeeder Technology
6.18.1 Beijing Succeeder Technology Company Information
6.18.2 Beijing Succeeder Technology Description and Business Overview
6.18.3 Beijing Succeeder Technology Blood Clotting Analysers Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Beijing Succeeder Technology Blood Clotting Analysers Product Portfolio
6.18.5 Beijing Succeeder Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Clotting Analysers Industry Chain Analysis
7.2 Blood Clotting Analysers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Clotting Analysers Production Mode & Process Analysis
7.4 Blood Clotting Analysers Sales and Marketing
7.4.1 Blood Clotting Analysers Sales Channels
7.4.2 Blood Clotting Analysers Distributors
7.5 Blood Clotting Analysers Customer Analysis
8 Blood Clotting Analysers Market Dynamics
8.1 Blood Clotting Analysers Industry Trends
8.2 Blood Clotting Analysers Market Drivers
8.3 Blood Clotting Analysers Market Challenges
8.4 Blood Clotting Analysers Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Blood Clotting Analysers was estimated to be worth US$ 3370 million in 2025 and is projected to reach US$ 5006 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 148
USD 3950.00
(Single User License)
The global Blood Clotting Analysers market size was US$ 3200 million in 2024 and is forecast to a readjusted size of US$ 4754 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 101
USD 4250.00
(Single User License)
The global Blood Clotting Analysers market is projected to grow from US$ 3200 million in 2024 to US$ 4754 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 179
USD 4900.00
(Single User License)
The global market for Blood Clotting Analysers was estimated to be worth US$ 3200 million in 2024 and is forecast to a readjusted size of US$ 4754 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 150
USD 3950.00
(Single User License)
The global market for Blood Clotting Analysers was valued at US$ 3200 million in the year 2024 and is projected to reach a revised size of US$ 4754 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-13
Pages: 104
USD 2900.00
(Single User License)
The global market for Blood Clotting Analysers was estimated to be worth US$ 3370 million in 2025 and is projected to reach US$ 5006 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 148
The global Blood Clotting Analysers market size was US$ 3200 million in 2024 and is forecast to a readjusted size of US$ 4754 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 101
The global Blood Clotting Analysers market is projected to grow from US$ 3200 million in 2024 to US$ 4754 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 179
The global market for Blood Clotting Analysers was estimated to be worth US$ 3200 million in 2024 and is forecast to a readjusted size of US$ 4754 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 150
The global market for Blood Clotting Analysers was valued at US$ 3200 million in the year 2024 and is projected to reach a revised size of US$ 4754 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-13
Pages: 104
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now